PACB
Pacific Biosciences of California, Inc.
stockNASDAQ
pacbio develops comprehensive solutions for scientists that propel the field of genomics, improve science and research, and create positive impact globally. we provide sophisticated genomic analysis systems that deliver invaluable insights for scientists who strive to resolve complex genetic challenges. our strength comes from the dedication of our people, who are fueled by a desire to effect real, positive change. with a focus on the future and an experienced, passionate team, we are motivated to continue to redefine what is possible in genomics.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 2.26 | 2026-11-06 | -13.30% | 2.891 |
| 1M | 2.05 | 2026-10-13 | -4.63% | 2.547 |
| 3M | 1.15 | 2026-08-13 | +70.00% | 2.612 |
| 6M | 1.27 | 2026-05-13 | +53.94% | 2.240 |
| 1Y | 1.63 | 2025-11-13 | +19.94% | 2.103 |
| 2Y | 1.98 | 2024-11-13 | -1.26% | — |
| 5Y | 27.32 | 2021-11-12 | -92.84% | 2.394 |
Pacific Biosciences of California, Inc. (NASDAQ:PACB) stock price today is $1.96, and today's volume is 6,576,374. PACB is down 0.761% today. The 30 day average volume is 15.18M. PACB market cap is $610.42M with 312.24M shares outstanding.